CELC NASDAQ
Celcuity Inc.
1W: +13.4%
1M: -14.5%
3M: -18.2%
YTD: -32.3%
1Y: -4.1%
3Y: +582.1%
5Y: +278.6%
$68.07
+2.27 (+3.45%)
Weekly Expected Move ±8.8%
$54
$59
$65
$71
$77
Credit Risk of going bust: higher than 68% of companies Debt: 18.5% of company value Bonds: $29.4M held by 33 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.93 (down 97%), Celcuity Inc. would be worth roughly what it owes.
Total debt $754.4M against a stock market value of $3.33B.
Distance to default 3.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $377.1M (short-term plus half of long-term), stock volatility 65.9%; Altman Z'' 1.75. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.93 (down 97%), Celcuity Inc. would be worth roughly what it owes.
Total debt $754.4M against a stock market value of $3.33B.
Distance to default 3.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $377.1M (short-term plus half of long-term), stock volatility 65.9%; Altman Z'' 1.75. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
13 relationships13
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-04-08
Earliest Filing
2025-09-10
Latest Filing
partner: 8
customer: 5
Counterparties (Filed by CELC)
13 relationshipsCompanies named in CELC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Celcuity Inc. | CELC | customer | Borrower in the loan agreement | 2025-09-10 | View |
| Celcuity Inc. | CELC | customer | Borrower in the loan agreement | 2025-07-29 | View |
| Celcuity Inc. | CELC | partner | Company issuing securities in the offering | 2024-05-31 | View |
| Leerink Partners LLC | — | partner | Underwriter and representative of the underwriters | 2024-05-31 | View |
| Stifel, Nicolaus & Company, Incorporated | — | partner | Underwriter and representative of the underwriters | 2024-05-31 | View |
| CeluCity, Inc. | — | customer | Borrower in the amended loan agreement | 2024-05-30 | View |
| Celcuity, Inc. | CELC | customer | Borrower in the Second Amendment to Loan and Security Agreement | 2024-03-29 | View |
| West Glen Development I, LLC | — | partner | Landlord in a lease amendment extending the term of a commercial lease. | 2023-03-15 | View |
| Celcuity, Inc. | CELC | partner | Tenant in a lease amendment extending the term of a commercial lease. | 2023-03-15 | View |
| Celcuity Inc. | CELC | partner | Company issuing the warrant | 2022-09-14 | View |
| Craig-Hallum Capital Group LLC | — | partner | Holder of the representative's warrant | 2022-09-14 | View |
| CELCUITY, INC. | CELC | customer | Borrower receiving term loans and entering into the amendment | 2022-08-11 | View |
| Pfizer, Inc. | PFE | partner | Licensee of exclusive worldwide rights to research, develop, manufacture, and commercialize gedatolisib; received upfron | 2021-04-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-02 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-09-30 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-26 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-07-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-08 | Material Agreement; Termination of Agreement; Financial Obligation; Other Events; Exhibits | Agreement | View |
| 2026-06-02 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-20 | Officer/Director Change | View | |
| 2026-05-18 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-05-01 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-25 | Earnings Release; Exhibits | View | |
| 2026-02-12 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-17 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-20 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-10 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-01 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR